Literature DB >> 19320641

RET protein promotes non-adherent growth of NB-39-nu neuroblastoma cell line.

Hitoyasu Futami1, Ryuichi Sakai.   

Abstract

The receptor tyrosine kinase RET is expressed in a number of neuroblastoma tissues and cell lines, but its role in neuroblastoma remains to be determined. In this study, we examined the roles of RET protein in neuroblastoma by the RNA interference technique using the NB-39-nu neuroblastoma cell line. NB-39-nu neuroblastoma cells show high expression and elevated tyrosine phosphorylation of RET, although short interfering RNA against RET (RET siRNA) did not significantly inhibit cell proliferation or suppression of basal levels of phosphorylation of extracellular regulated kinase (ERK)1/2 or protein kinase B (AKT). By the addition of glial cell line-derived neurotrophic factor (GDNF), both the expression and phosphorylation of RET and the phosphorylation of ERK1/2 and AKT were further increased, whereas cell proliferation was not stimulated under normal culture conditions. However, proliferation of cells cultured under non-adherent conditions was significantly increased by GDNF. The increased proliferation was suppressed by RET siRNA, which also caused inhibition of the phosphorylation of ERK1/2 and AKT. These results suggest that RET signaling plays an important role in GDNF-induced enhancement of non-adherent proliferation of NB-39-nu cells, which might contribute to the metastasis of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320641     DOI: 10.1111/j.1349-7006.2009.01143.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  6 in total

1.  BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Authors:  Frauke Kramer; Timo Stöver; Athanasia Warnecke; Marc Diensthuber; Thomas Lenarz; Kirsten Wissel
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

2.  Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo.

Authors:  Zhenghu Chen; Yanling Zhao; Yang Yu; Jonathan C Pang; Sarah E Woodfield; Ling Tao; Shan Guan; Huiyuan Zhang; Shayahati Bieerkehazhi; Yan Shi; Roma Patel; Sanjeev A Vasudevan; Joanna S Yi; Jodi A Muscal; Guo-Tong Xu; Jianhua Yang
Journal:  Oncotarget       Date:  2017-10-24

Review 3.  Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.

Authors:  Esteban Javier Rozen; Jason Matthew Shohet
Journal:  Cancer Metastasis Rev       Date:  2021-10-30       Impact factor: 9.264

4.  Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma.

Authors:  Bradley D DeNardo; Michael P Holloway; Qinqin Ji; Kevin T Nguyen; Yan Cheng; Marcus B Valentine; Arthur Salomon; Rachel A Altura
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

Review 5.  Cell Proliferation in Neuroblastoma.

Authors:  Laura L Stafman; Elizabeth A Beierle
Journal:  Cancers (Basel)       Date:  2016-01-12       Impact factor: 6.639

6.  The role of the ShcD and RET interaction in neuroblastoma survival and migration.

Authors:  Zeanap A Mabruk; Samrein B M Ahmed; Asha Caroline Thomas; Sally A Prigent
Journal:  Biochem Biophys Rep       Date:  2018-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.